Literature DB >> 1933902

A germ line mutation in exon 5 of the p53 gene in an extended cancer family.

J C Law1, L C Strong, A Chidambaram, R E Ferrell.   

Abstract

Germ line p53 point mutations have been reported for some families with Li-Fraumeni syndrome, a syndrome characterized by a dominantly inherited increased susceptibility for the development of early age of onset neoplasms of diverse origin in multiple family members. All of the initially reported p53 germ line mutations have been found exclusively within a single conserved, nonpolymorphic region of the gene between condons 245 and 258. The restricted distribution of these inherited mutations has led to speculation that germ line p53 mutations have unique properties [B. Vogelstein, Nature (Lond.), 348: 681-682, 1990]. We report here on the identification of a p53 germ line mutation at codon 133 (ATG----ACG) in nine members of an extended Li-Fraumeni syndrome family. This mutation leads to an amino acid substitution in the protein and is shown to completely cosegregate with Li-Fraumeni syndrome associated cancer in this family. Its location extends the region of the p53 gene where inherited mutations predisposing to cancer are observed and suggests that their distribution may be diverse.

Entities:  

Mesh:

Year:  1991        PMID: 1933902

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

Review 1.  Cancer risks from germline p53 mutations.

Authors:  T Frebourg; S H Friend
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.

Authors:  E D Lustbader; W R Williams; M L Bondy; S Strom; L C Strong
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 3.  Etiology of Balkan endemic nephropathy: a multifactorial disease?

Authors:  D Toncheva; T Dimitrov; S Stojanova
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

4.  Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.

Authors:  T Frebourg; J Kassel; K T Lam; M A Gryka; N Barbier; T I Andersen; A L Børresen; S H Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 5.  Tumors associated with p53 germline mutations: a synopsis of 91 families.

Authors:  P Kleihues; B Schäuble; A zur Hausen; J Estève; H Ohgaki
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 7.  Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Authors:  April D Sorrell; Carin R Espenschied; Julie O Culver; Jeffrey N Weitzel
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

8.  Prognostic significance of p53 gene alterations in node-negative breast cancer.

Authors:  R M Elledge; S A Fuqua; G M Clark; P Pujol; D C Allred; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer.

Authors:  R M Elledge; S A Fuqua; G M Clark; P Pujol; D C Allred
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome.

Authors:  J W Shay; G Tomlinson; M A Piatyszek; L S Gollahon
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.